• Exchange: NASDAQ CM
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Biotech

OXGN:US

2.8000 USD 0.1800 6.04%

As of 20:10:00 ET on 04/17/2014.

Snapshot for OXiGENE Inc (OXGN)

Open: 2.9000 Day's Range: 2.7400 - 3.0200 Volume: 977,093
Previous Close: 2.9800 52wk Range: 1.9600 - 5.4000 1-Yr Rtn: -20.68%

Stock Chart for OXGN

No chart data available.
  • OXGN:US 2.8000
  • 1D
  • 1M
  • 1Y
2.9800
Interactive OXGN Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for OXGN

Current P/E Ratio (ttm) -
Estimated P/E(12/2014) -
Relative P/E vs. SPX -
Earnings Per Share (USD) (ttm) -4.6700
Est. EPS (USD) (12/2014) -
Est. PEG Ratio -
Market Cap (M USD) 42.66
Shares Outstanding (M) 15.24
30 Day Average Volume 2,903,543
Price/Book (mrq) 1.0897
Price/Sale (ttm) 77.8105
Dividend Indicated Gross Yield -%
Cash Dividend -
Dividend Ex-Date
5 Year Dividend Growth -
Next Earnings Announcement 05/06/2014
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for OXGN

  • Revenue
  • Net Income (M/USD)
  • Profit Margin (%)

Company Profile & Key Executives for OXGN

OXiGENE Inc. is a pharmaceutical company that develops therapeutics to treat cancer and eye diseases. The Company focuses on the clinical advancement of drug candidates that selectively disrupt abnormal blood vessels associated with solid tumor progression and visual impairment.

Peter J LangeckerChairman/CEOBarbara RichingVP/CFO
More Company Profile & Key Executives for OXGN

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil